Naproxen

Formulation

The table below describes the formulation of naproxen sodium and the controls morphine sulfate and gabapentin for the experiments shown on this page.

Experiment(s)	Compound	Dose(s) mg/kg	Correction factor	Dose volume mL/kg	Route	Vehicle	Suspension / Solution
Pharmacokinetics	Naproxen	1, 10	1.10	1	PO	Water	Solution
Irwin, Rotarod	Naproxen	3, 10, 30, 100	1.10	1	PO	Water	Solution
Plantar Incision,	Naproxen	1, 3, 10, 30	1.10	1	PO	Water	Solution
L5/L6 SNL	Naproxen	1, 3, 10, 30	1.10	1	PO	Water	Solution
Plantar Incision	Morphine	6	1.33	1	SC	Saline	Solution
L5/L6 SNL	Gabapentin	60	1.00	1	PO	Saline	Solution

L5/L6 SNL = L5/L6 spinal nerve ligation; PO = per os; SC = subcutaneous

Results

Expand and Collapse accordion content

Method: Pharmacokinetics

Naproxen concentrations were measured in serially collected plasma samples and terminally collected brain samples (shown on two graphs) from males and females treated with 1 or 10 mg/kg naproxen (PO) in a vehicle of water. There were 3-4 rats/group.

Method: Pharmacokinetics

A table shows pharmacokinetics parameters calculated for naproxen using non-compartmental analysis in male and female rats treated with naproxen (1 or 10 mg/kg, PO, vehicle of water). The means for the 4 groups (males and females treated with 1 mg/kg naproxen and males and females treated with 10 mg/kg naproxen, respectively) are as follows. The highest concentration (Cmax) was 11.74, 14.5, 115, and 151.2 µM; the time at the maximum concentration (Tmax) was 0.69, 1.13, 1.67, and 1.75 hours; the half-life (T1/2) was 6.24, 4.78, 7.13, and 4.56 hours; area under the curve for time 0 to 8 hours was 1095, 4942, 36510, and 46854 minutes*µM; area under the curve for time 0 to infinity was 6876, 7221, 71142, and 70005 minutes*µM; the brain-to-plasma ratio at 2 hours was 0.031, 0.031, 0.028, and 0.032; the brain-to-plasma ratio at 8 hours was 0.026, 0.031, 0.028, and 0.026.

Method: Modified Irwin functional observational battery

Two reviewers observed and scored 39 behaviors in a modified Irwin test. For each animal, the scores for behavioral observations from each reviewer are summed then averaged for male and female rats (shown on two graphs). Responses are shown at the following time points: baseline (before treatment) and at 1, 2, 4, and 6 hours after treatment with vehicle (water, delivered PO) or naproxen (3, 10, 30, or 100 mg/kg, delivered PO). There were 4 rats per group. Kruskal-Wallis tests were performed at each timepoint for each sex, and no significant effects were observed. Data were analyzed using GraphPad Prism version 10.0.2

Method: Modified Irwin functional observational battery

A heat map depicts the severity of the behaviors observed by two reviewers in a modified Irwin test at baseline and at 1, 2, 4, and 6 hours following the administration of vehicle (water, delivered PO) or naproxen (3, 10, 30, or 100 mg/kg, delivered PO). There were 8 rats per group (4 male and 4 female). Severity score was calculated as the sum of scores given by the two reviewers for all animals at that dose and timepoint divided by the maximum possible score, transformed into a percentage. In summary, naproxen administration was well tolerated at all doses

Method: Modified Irwin functional observational battery

Two graphs show the body temperature of male or female rats during the modified Irwin test. Responses are shown at the following timepoints: baseline (before treatment) and at 1 and 6 hours after treatment with vehicle (water, delivered PO) or naproxen (3, 10, 30, or 100 mg/kg, delivered PO). There were 4 rats per group. Dunnett’s tests performed after finding significant effects of time in a two-way repeated measures ANOVA for each sex showed a significant decrease in body temperature after 6 hours relative to baseline for both males and females (p<0.05 for each comparison). Data were analyzed using GraphPad Prism version 10.0.2

Method: Rat Rotarod

Two graphs show the latency for male or female rats to fall off a rotarod apparatus. Responses are shown at the following time points: baseline (before treatment) and at 0.5, 1, and 2 hours after treatment with vehicle (water, delivered PO) or naproxen (3, 10, 30, or 100 mg/kg, delivered PO). There were 10 rats per group. Neither males nor females had a significant interaction of time x treatment in a two-way repeated measures ANOVA.

Model: Plantar Incision Model in Rat (Brennan Model)
Endpoint: Rat Hind Paw Mechanical Allodynia Behavior (von Frey Filaments) Method

Two graphs show ipsilateral hind paw mechanical allodynia behavior assessed with von Frey filaments in male or female rats that have undergone plantar incision surgery. Responses are shown at the following time points: baseline (before surgery), prior to treatment at 1 day after surgery, and at 1, 2, 4, and 6 hours after treatment at 1 day after surgery. The treatments are vehicle (water, delivered PO), naproxen (1, 3, 10, or 30 mg/kg, delivered PO), or the positive control morphine (6 mg/kg, delivered SC). There were 10 rats per group. A significant interaction of time x treatment was found in a two-way repeated measures ANOVA. Dunnett’s tests found significant differences from vehicle in males at 1 hour post-treatment with 1, 3, 10, and 30 mg/kg naproxen (p<0.001, 0.01, 0.01, 0.001, respectively) and morphine (p<0.0001); at 2 hours post-treatment with 3, 10, and 30 mg/kg naproxen (p<0.01, 0.01, 0.001, respectively) and morphine (p<0.0001); at 4 hours post-treatment with 1 mg/kg naproxen (p<0.05), 30 mg/kg naproxen (p<0.05), and morphine (p<0.0001); and at 6 hours post-treatment with morphine (p<0.001). Dunnett’s tests found significant differences from vehicle in females at 1 hour post-treatment with morphine (p<0.0001) and at 2 hours post-treatment with morphine (p<0.0001).

Model: Plantar Incision Model in Rat (Brennan Model)
Endpoint: Guarding Behavior

Two graphs show ipsilateral hind paw guarding behavior evaluated in male or female rats that have undergone plantar incision surgery. Responses are shown at the following time points: baseline (before surgery), prior to treatment at 1 day after surgery, and at 1, 2, 4, and 6 hours after treatment at 1 day after surgery. The treatments are vehicle (water, delivered PO), naproxen (1, 3, 10, or 30 mg/kg, delivered PO), or the positive control morphine (6 mg/kg, delivered SC). There were 10 rats per group. A significant interaction of time x treatment was found in a two-way repeated measures ANOVA. Dunnett’s tests found significant differences from vehicle in males at 1 hour and 2 hours post-treatment with morphine (p<0.0001 for both comparisons). Dunnett’s tests found significant differences from vehicle in females at 1 hour and 2 hours post-treatment with morphine (p<0.0001 for both comparisons).

Model: L5/L6 Spinal Nerve Ligation Model
Endpoint: Rat Hind Paw Mechanical Allodynia Behavior (von Frey Filaments) Method

Model: L5/L6 Spinal Nerve Ligation Model
Endpoint: Rat Hind Paw Cold Allodynia (Acetone Evaporation) Test

Two graphs show ipsilateral hind paw cold allodynia behavior assessed with 5 trials of the acetone evaporation test in male or female rats that have undergone L5/L6 spinal nerve ligation surgery. Responses are shown at the following time points: baseline (before surgery), prior to treatment at 3 weeks after surgery, and at 1 and 3 hours after treatment at 3 weeks after surgery. The treatments are vehicle (water, delivered PO), naproxen (1, 3, 10, or 30 mg/kg, delivered PO), or the positive control gabapentin (60 mg/kg, delivered PO). There were 10 rats per group. A significant interaction of time x treatment was found in a two-way repeated measures ANOVA. Dunnett’s tests found a significant difference from vehicle in males at 1 hour post-treatment with gabapentin (p<0.01). Dunnett’s tests found significant differences from vehicle in females at 1 hour post-treatment with 3 mg/kg naproxen (p<0.05) and gabapentin (p<0.01).

This work was conducted by PsychoGenics Inc. (Paramus, NJ) in collaboration with PSPP, NINDS, NIH under contract # 75N95019D00026. Prescribing information for clinically used controls can be found at labels.fda.gov.

Naproxen

Formulation

Results

Pharmacokinetics: Concentration in Plasma and Brain

Pharmacokinetics: Calculated Parameters

Irwin: Total Observations

Irwin: Behavioral Severity Scores

Irwin: Body Temperature

Rotarod

Plantar Incision: von Frey

Plantar Incision: Guarding Behavior

L5/L6 Spinal Nerve Ligation: von Frey

L5/L6 Spinal Nerve Ligation: Acetone